Literature DB >> 12790252

Effect of valued activity disability, social comparisons, and satisfaction with ability on depressive symptoms in rheumatoid arthritis.

Alyson Neugebauer1, Patricia P Katz, Lauri A Pasch.   

Abstract

This longitudinal study identified a model through which function affects the psychologicalwell-being of individuals with rheumatoid arthritis (RA). Results of hierarchical linear regression analyses (N = 436) demonstrated that greater physical impairment resulted in greater disability in valued activities and engagement in unfavorable social comparisons. All 3 factors--greater physical impairment, greater disability in valued activities, and unfavorable comparison evaluations--predicted low satisfaction with abilities. Low satisfaction with abilities was the most important predictor of higher depressive symptoms and mediated the impact of physical impairment, valued activity disability, and unfavorable comparisons on depressive symptoms. Results highlight the role of personal meaning attached to changes in functional status in predicting the long-term psychological well-being of individuals with chronic illnesses such as RA.

Entities:  

Mesh:

Year:  2003        PMID: 12790252     DOI: 10.1037/0278-6133.22.3.253

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  14 in total

1.  Temporal associations between the different domains of rheumatoid arthritis disease activity and the onset of patient-reported depressive symptoms.

Authors:  Alan M Rathbun; Leslie R Harrold; George W Reed
Journal:  Clin Rheumatol       Date:  2014-08-27       Impact factor: 2.980

Review 2.  Strength and vulnerability integration: a model of emotional well-being across adulthood.

Authors:  Susan Turk Charles
Journal:  Psychol Bull       Date:  2010-11       Impact factor: 17.737

3.  Physical activity in prefrail older adults: confidence and satisfaction related to physical function.

Authors:  W Jack Rejeski; Abby C King; Jeffrey A Katula; Stephen Kritchevsky; Michael E Miller; Michael P Walkup; Nancy W Glynn; Marco Pahor
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2008-01       Impact factor: 4.077

4.  Serious psychological distress in U.S. adults with arthritis.

Authors:  Margaret Shih; Jennifer M Hootman; Tara W Strine; Daniel P Chapman; Teresa J Brady
Journal:  J Gen Intern Med       Date:  2006-07-19       Impact factor: 5.128

5.  Pain and functional impairment as mediators of the link between medical symptoms and depression in type 2 diabetes.

Authors:  William P Sacco; Cathy A Bykowski; Laura L Mayhew
Journal:  Int J Behav Med       Date:  2013-03

6.  Momentary Associations of Osteoarthritis Pain and Affect: Depression as Moderator.

Authors:  Patricia A Parmelee; Emily A Behrens; Kyrsten Costlow Hill; Brian S Cox; Jason A DeCaro; Francis J Keefe; Dylan M Smith
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2022-07-05       Impact factor: 4.942

Review 7.  Integrating co-morbid depression and chronic physical disease management: identifying and resolving failures in self-regulation.

Authors:  Jerusha B Detweiler-Bedell; Michael A Friedman; Howard Leventhal; Ivan W Miller; Elaine A Leventhal
Journal:  Clin Psychol Rev       Date:  2008-09-09

8.  Valued life activity disability played a significant role in self-rated health among adults with chronic health conditions.

Authors:  Patricia Katz; Anne Morris; Steve Gregorich; Jinoos Yazdany; Mark Eisner; Edward Yelin; Paul Blanc
Journal:  J Clin Epidemiol       Date:  2008-08-22       Impact factor: 6.437

9.  Perceived difficulty, importance, and satisfaction with physical function in COPD patients.

Authors:  Jeffrey A Katula; W Jack Rejeski; Katie L Wickley; Michael J Berry
Journal:  Health Qual Life Outcomes       Date:  2004-03-31       Impact factor: 3.186

10.  Enhancing quality of life in older adults: a comparison of muscular strength and power training.

Authors:  Jeffrey A Katula; W Jack Rejeski; Anthony P Marsh
Journal:  Health Qual Life Outcomes       Date:  2008-06-13       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.